Oral methotrexate at doses 15–25 mg/week is non-inferior to parenteral regarding efficacy and safety in the treatment of rheumatoid arthritis: a systematic review and meta-analysis
Fang Wang, Jingliang Tang, Zhe Li, Yanyan Qi, Ganpeng Li, Fang Wang
Topics & Concepts
MedicineInternal medicineRheumatoid arthritisMethotrexateRheumatologyMeta-analysisAdverse effectOdds ratioConfidence intervalCmaxRandomized controlled trialGastroenterologyPharmacokineticsRheumatoid Arthritis Research and TherapiesAutoimmune and Inflammatory Disorders ResearchSpondyloarthritis Studies and Treatments